HPLC and SFC enantioseparation of (±)‐Corey lactone diol: Impact of the amylose tris‐(3,5‐dimethylphenylcarbamate) coating amount on chiral preparation

As an important intermediate of prostaglandins and entecavir, optically pure Corey lactone diol (CLD) has great value in the pharmaceutical industry. In this work, the enantioseparation of (±)‐CLD was evaluated using high‐performance liquid (HPLC) and supercritical fluid chromatography (SFC). In HPLC, the separations of CLD enantiomers on polysaccharide‐based chiral stationary phases with both normal phase and polar organic phase were screened. And the conditions for the enantioseparation were optimized in HPLC and SFC, including the selection of mobile phase, temperature, back‐pressure, and other conditions. More important, it was found that the chiral resolutions were greatly enhanced by the increase of the coating amount of ADMPC (amylose tris‐(3,5‐dimethylphenylcarbamate)) under both HPLC and SFC conditions, which can lead to the increase of the productivity and the decrease of the solvent consumption. The preparations of optically pure CLD were evaluated on a semi‐preparative (2 × 25 cm) column packed with 30% ADMPC‐coated CSP under HPLC and SFC conditions. Preparative performances in terms of kkd are 1.536 kg racemate/kg CSP/day and 1.248 kg racemate/kg CSP/day in HPLC and SFC, respectively.     

无透镜显微技术

无透镜显微成像(lens-free microscopy)是一种在不借助透镜的情况下进行成像的技术。它基于Gabor同轴全息原理,利用面阵探测器采集原始全息图,随后通过数字图像处理技术重建样本,从而实现数字显微成像。像素超分辨技术缩小了等效像素,提供更多细节信息使得再现像的分辨率得以直接提升,而且多种相位恢复手段通过去除孪生像也达到了间接提高分辨率的目的,尤其是对密集样本。无透镜显微成像技术突破了传统光学显微镜由透镜带来的空间带宽积的限制,实现了大视野范围下的高分辨率成像,因此,这一技术能够提供大视场下的临床样本快速诊断和准确检测。另外,新兴的算法和硬件都在不断地加快数据采集和计算速度,扩展了其在高速运动样本和纳米尺度样本上的应用。最近无透镜技术和其配套硬件设备发展方向趋向于硬件紧凑、算法密集、实时、三维、彩色、高分辨率的便携式分立器件或配件。     

Butylene fipronil induces apoptosis in PC12 murine nervous cells via activation of p16‐CDK4/6‐cyclin D1 and mitochondrial apoptotic pathway

Butylene fipronil (BFPN) is a phenylpyrazole insecticide, acting at the γ‐aminobutyric acid (GABA) receptor. Here, we show that BFPN inducedcytotoxicity in PC12 murinenervous cells, which lacks GABA receptor. Treatment with BFPN for 48 hours significantly enhanced G0/G1 arrest and induced apoptosis. BFPN decreased the expression of cyclin‐dependent kinase (CDK4 and CDK6) and increased P16 and cyclin D1. Simultaneously, Bcl‐2 protein was declined while Bax and cytochrome c were significantly enhanced in BFPN‐treated groups. The apoptotic enzymes caspase‐8, ‐9, and ‐3 were also activated by BFPN. Furthermore, treatment with BFPN significantly stimulated reactive oxygen species (ROS) generation, and pretreatment with antioxidant diphenyleneiodonium, substantially reduced cell death. Overall, these results suggest that BFPN is effective to induce G0/G1‐phase arrest and apoptosis in PC12 murine nervous cell. Stimulating ROS generation and activation of P16‐CDK4/6‐cyclin D1 and mitochondrial apoptotic pathway may participate in the cytotoxicity of BFPN.     

青少年慢性粒细胞白血病急变临床分析

目的:分析青少年慢性粒细胞白血病(CGL)急变患者临床表现及实验检查特点,以提高对青少年CGL急变临床特点的认识。方法:将CGL急变患者按年龄分组,将青少年组和中老年组患者的急变时间、确诊时和急变时的脾脏大小、白细胞和血小板数目、急变时骨髓幼稚细胞的比例,以及患者的总生存时间、急变后生存时间进行对比分析。结果:青少年组和中老年组的脾脏大小、确诊时血小板数目、急变时的白细胞数目、急变时间、以及总生存时间无显著性差异;青少年组确诊时的白细胞数目较中老年组高,青少年组的急变后生存时间较长。结论:青少年CGL患者的临床表现及实验室检查结果具有CGL的普遍特征,但其确诊时白细胞数目较高,急变后生存时间较长。     

Clinical trials and SCID row: the ethics of phase 1 trials in the developing world

Relatively little has been written about the ethics of conducting early phase clinical trials involving subjects from the developing world. Below, I analyze ethical issues surrounding one of gene transfer's most widely praised studies conducted to date: in this study, Italian investigators recruited two subjects from the developing world who were ineligible for standard of care because of economic considerations. Though the study seems to have rendered a cure in these two subjects, it does not appear to have complied with various international guidelines that require that clinical trials conducted in the developing world be responsive to their populations' health needs. Nevertheless, policies devised to address large scale, late stage trials, such as the AZT short-course placebo trials, map somewhat awkwardly to early phase studies. I argue that interest in conducting translational research in the developing world, particularly in the context of hemophilia trials, should motivate more rigorous ethical thinking around clinical trials involving economically disadvantaged populations.     

Fluorescently labeled adrenomedullin allows real‐time monitoring of adrenomedullin receptor trafficking in living cells

The human adrenomedullin (ADM) is a 52 amino acid peptide hormone belonging to the calcitonin family of peptides, which plays a major role in the development and regulation of cardiovascular and lymphatic systems. For potential use in clinical applications, we aimed to investigate the fate of the peptide ligand after binding and activation of the adrenomedullin receptor (AM₁), a heterodimer consisting of the calcitonin receptor‐like receptor (CLR), a G protein‐coupled receptor, associated with the receptor activity‐modifying protein 2 (RAMP2). Full length and N‐terminally shortened ADM peptides were synthesized using Fmoc/tBu solid phase peptide synthesis and site‐specifically labeled with the fluorophore carboxytetramethylrhodamine (Tam) either by amide bond formation or copper(I)‐catalyzed azide alkyne cycloaddition. For the first time, Tam‐labeled ligands allowed the observation of co‐internalization of the whole ligand‐receptor complex in living cells co‐transfected with fluorescent fusion proteins of CLR and RAMP2. Application of a fluorescent probe to track lysosomal compartments revealed that ADM together with the CLR/RAMP2‐complex is routed to the degradative pathway. Moreover, we found that the N‐terminus of ADM is not a crucial component of the peptide sequence in terms of AM₁ internalization behavior. Copyright © 2015 European Peptide Society and John Wiley & Sons, Ltd.     

Should reference conditions be drawn from a single 10 ha plot? Assessing representativeness in a 10,000 ha old‐growth European beech forest

The management targets of modern forestry are often dictated by a desire to restore natural conditions, largely considered to be those found in contemporary reference sites. Beech reference sites are usually subjectively placed plots located in old‐growth reserves. Given the inherent variability in old‐growth, the validity of using a single such plot to guide restoration efforts is questionable. We therefore applied 3 methods to assess the representativeness of a 10 ha research plot in an old‐growth European beech (Fagus sylvatica L.) forest in Ukraine compared to an inventory of the entire 10,282 ha forest reserve. We compared the research plot to the 500‐m² inventory plots using (1) permutation tests of structure metrics, (2) synthetic multivariate structural condition, and (3) functional condition via the proportion of area assigned to 8 forest development phases. Despite up to 82% distributional overlap for some metrics, both the averages and distributions of individual structural metrics (e.g. basal area, tree diameters) differed significantly between the RP and the inventory, as did the synthetic structural condition and the proportion of late optimal and decay phases. Extrapolations from this subjectively placed plot to the surrounding old‐growth matrix would overestimate several stereotypical “old‐growth” structures. These results support the need to draw on multiple reference sites and metrics and to select restoration target conditions that account for the variability associated with naturally dynamic ecosystems. A lack of absolute representativeness does not, however, necessarily preclude the generalizability of process‐based dynamics from old‐growth remnants.